Welcome to

Better drugs for back pain to improve treatment outcomes, lower patient risk, and reduce treatment costs.

Latest News

Foster and Wood Join Board

SpineThera Featured at BIO - NIH SBIR Innovation Zone

What We Do

SpineThera designs and develops sustained-release, injectable drugs to meet the unique safety requirements for administration in and near the spine. Our proprietary drugs offer patients and physicians new treatment options that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs.

Why We Do It

  • Patients benefit from fewer injections, less risk, and long-term therapeutic benefit.
  • Physicians improve their productivity by treating more patients successfully.
  • Payers reduce their overall treatment costs.